NO883986L - Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter. - Google Patents
Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.Info
- Publication number
- NO883986L NO883986L NO88883986A NO883986A NO883986L NO 883986 L NO883986 L NO 883986L NO 88883986 A NO88883986 A NO 88883986A NO 883986 A NO883986 A NO 883986A NO 883986 L NO883986 L NO 883986L
- Authority
- NO
- Norway
- Prior art keywords
- acridinamines
- alkylide
- tetrahydro
- medicines
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9393587A | 1987-09-08 | 1987-09-08 | |
| US07/223,846 US5013741A (en) | 1987-09-08 | 1988-07-25 | N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO883986D0 NO883986D0 (no) | 1988-09-07 |
| NO883986L true NO883986L (no) | 1989-03-09 |
Family
ID=26788073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO88883986A NO883986L (no) | 1987-09-08 | 1988-09-07 | Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5013741A (pt) |
| EP (1) | EP0306825B1 (pt) |
| JP (1) | JP2641915B2 (pt) |
| KR (1) | KR890005058A (pt) |
| AU (1) | AU620043B2 (pt) |
| CA (1) | CA1334669C (pt) |
| DE (1) | DE3889043T2 (pt) |
| DK (1) | DK167251B1 (pt) |
| ES (1) | ES2053652T3 (pt) |
| FI (1) | FI89478C (pt) |
| HU (1) | HU201017B (pt) |
| IE (1) | IE63027B1 (pt) |
| IL (1) | IL87679A0 (pt) |
| NO (1) | NO883986L (pt) |
| NZ (1) | NZ226054A (pt) |
| PT (1) | PT88444B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4868177A (en) * | 1988-11-09 | 1989-09-19 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,2,3,4-tetrahydro-1,9-acridinediamines, pharmaceutical compositions and use |
| JPH02180871A (ja) * | 1988-11-16 | 1990-07-13 | Hoechst Roussel Pharmaceut Inc | ヒドロキシ―１，２，３，４―テトラヒドロアミノアクリジンおよびその製造法 |
| US5175172A (en) * | 1988-12-19 | 1992-12-29 | Francois Dietlin | Method of alleviating AIDS symptoms and compositions therefor |
| FR2640508B1 (fr) * | 1988-12-19 | 1994-07-01 | Dietlin Francois | Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire |
| US5149813A (en) * | 1989-06-26 | 1992-09-22 | Hoechst-Roussel Pharmaceuticals Incorporated | Process for (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds |
| WO1995003052A1 (en) * | 1993-07-22 | 1995-02-02 | Warner-Lambert Company | Controlled release tacrine drug delivery systems and methods for preparing same |
| CN108047202B (zh) * | 2017-12-20 | 2021-06-11 | 东南大学 | 一种铝离子响应型化合物及其制备方法与应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3232945A (en) * | 1962-08-13 | 1966-02-01 | S E Massengill Company | 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines |
| US3318895A (en) * | 1963-12-05 | 1967-05-09 | Squibb & Sons Inc | Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines |
| US3318896A (en) * | 1963-12-05 | 1967-05-09 | Squibb & Sons Inc | Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines |
| BE658695A (pt) * | 1964-02-03 | 1965-07-22 | ||
| US3580915A (en) * | 1968-09-16 | 1971-05-25 | American Home Prod | 1,2,3,4-tetrahydrobenzol(b)(1,6)naphthyridine derivatives |
| US3541066A (en) * | 1968-09-16 | 1970-11-17 | American Home Prod | 2,3-dihydro-1,4-ethanobenzo(b)(1,5)naphthyridine derivatives |
| US3657233A (en) * | 1970-04-30 | 1972-04-18 | American Home Prod | 10-morpholino-1 2 3 4-tetrahydrobenzo(b)(1 6)naphthyridine derivatives |
| US3637706A (en) * | 1970-04-30 | 1972-01-25 | American Home Prod | 10-(4 - (lower)alkylpiperazino) - 1 2 3 4-tetrahydrobenzo(b)(1 6) naphthyridine derivatives useful as cns depressants |
| US3647800A (en) * | 1970-04-30 | 1972-03-07 | American Home Prod | 10-substituted - 1 2 3 4 - tetrahydrobenzo(b)(1 6)naphthyridines useful as cns depressants |
| US3674790A (en) * | 1970-05-01 | 1972-07-04 | American Home Prod | 2,10-disubstituted-1,2,3,4-tetrahydrobenzo(bhq (1,6)naphthyridines useful as cns depressants |
| ES431307A1 (es) * | 1973-11-16 | 1976-09-01 | Thomae Gmbh Dr K | Procedimiento para la preparacion de nuevos derivados de quinoleina. |
| US4108998A (en) * | 1976-11-08 | 1978-08-22 | American Home Products Corp. | Furo[3,4-b]quinoline derivatives and pharmaceutical compositions and methods employing them |
| US4575553A (en) * | 1984-06-18 | 1986-03-11 | Bristol-Myers Company | Antitumor m-AMSA analog |
| ATE63903T1 (de) * | 1984-10-25 | 1991-06-15 | Hoechst Roussel Pharma | 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel. |
| US4631286A (en) * | 1984-10-25 | 1986-12-23 | Hoechst-Roussel Pharmaceuticals Inc. | 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds |
| US4695573A (en) * | 1984-10-25 | 1987-09-22 | Hoechst-Roussel Pharmaceuticals Inc. | 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds |
| US4816456A (en) * | 1986-10-01 | 1989-03-28 | Summers William K | Administration of monoamine acridines in cholinergic neuronal deficit states |
| DK569087A (da) * | 1986-10-31 | 1988-05-01 | Sumitomo Pharma | Quinolin-derivater, deres fremstilling og anvendelse |
| US4762841A (en) * | 1987-03-30 | 1988-08-09 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 9-amino-spiro(cycloalkyl(b)quinoline-2,1'cycloalkanes) |
| US4851536A (en) * | 1987-05-07 | 1989-07-25 | American Home Products Corporation | Cyclohexylquinolines as inhibitors of interleukin 1 |
| IL87861A0 (en) * | 1987-10-05 | 1989-03-31 | Pfizer | 4-aminopyridine derivatives |
| WO1989002739A1 (en) * | 1987-10-05 | 1989-04-06 | Pfizer Inc. | 4-aminopyridine derivatives |
| US4985430A (en) * | 1987-12-03 | 1991-01-15 | Mitsubishi Kasei Corporation | 9-acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient |
-
1988
- 1988-07-25 US US07/223,846 patent/US5013741A/en not_active Expired - Lifetime
- 1988-09-01 DE DE3889043T patent/DE3889043T2/de not_active Expired - Fee Related
- 1988-09-01 EP EP88114248A patent/EP0306825B1/en not_active Expired - Lifetime
- 1988-09-01 ES ES88114248T patent/ES2053652T3/es not_active Expired - Lifetime
- 1988-09-06 IL IL87679A patent/IL87679A0/xx not_active IP Right Cessation
- 1988-09-06 FI FI884104A patent/FI89478C/fi not_active IP Right Cessation
- 1988-09-06 NZ NZ226054A patent/NZ226054A/xx unknown
- 1988-09-07 KR KR1019880011521A patent/KR890005058A/ko not_active Application Discontinuation
- 1988-09-07 PT PT88444A patent/PT88444B/pt not_active IP Right Cessation
- 1988-09-07 NO NO88883986A patent/NO883986L/no unknown
- 1988-09-07 DK DK497888A patent/DK167251B1/da not_active IP Right Cessation
- 1988-09-07 AU AU21936/88A patent/AU620043B2/en not_active Ceased
- 1988-09-07 CA CA000576693A patent/CA1334669C/en not_active Expired - Fee Related
- 1988-09-07 JP JP63222590A patent/JP2641915B2/ja not_active Expired - Fee Related
- 1988-09-07 IE IE270388A patent/IE63027B1/en not_active IP Right Cessation
- 1988-09-08 HU HU884630A patent/HU201017B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI884104A0 (fi) | 1988-09-06 |
| IE882703L (en) | 1989-03-08 |
| PT88444B (pt) | 1992-10-30 |
| FI89478B (fi) | 1993-06-30 |
| EP0306825A1 (en) | 1989-03-15 |
| DK167251B1 (da) | 1993-09-27 |
| KR890005058A (ko) | 1989-05-11 |
| EP0306825B1 (en) | 1994-04-13 |
| FI884104A (fi) | 1989-03-09 |
| DK497888A (da) | 1989-03-09 |
| PT88444A (pt) | 1989-07-31 |
| JPH01131160A (ja) | 1989-05-24 |
| NO883986D0 (no) | 1988-09-07 |
| HUT49332A (en) | 1989-09-28 |
| DE3889043D1 (de) | 1994-05-19 |
| DK497888D0 (da) | 1988-09-07 |
| FI89478C (fi) | 1993-10-11 |
| DE3889043T2 (de) | 1994-10-06 |
| NZ226054A (en) | 1991-08-27 |
| JP2641915B2 (ja) | 1997-08-20 |
| AU620043B2 (en) | 1992-02-13 |
| CA1334669C (en) | 1995-03-07 |
| IL87679A0 (en) | 1989-02-28 |
| HU201017B (en) | 1990-09-28 |
| US5013741A (en) | 1991-05-07 |
| AU2193688A (en) | 1989-03-09 |
| ES2053652T3 (es) | 1994-08-01 |
| IE63027B1 (en) | 1995-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO892083D0 (no) | Fremgangsmaate for fremstilling av arylmetylenyl-derivaterav tiazolidinoner, imidazolidinoner og oksazolidinoner. | |
| NO871640L (no) | Fremgangsmaate for fremstilling av n-(2[-aminofenyl)-benzamidderivater. | |
| NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
| NO890269D0 (no) | Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser. | |
| NO894539L (no) | Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater. | |
| NO871052D0 (no) | 1,1-disubstituerte cyklopropanderivater, fremgangsmaate til deres fremstilling og deres anvendelse. | |
| NO880473L (no) | Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel. | |
| NO893826D0 (no) | Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater. | |
| NO900643L (no) | Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater. | |
| NO165104C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater. | |
| NO883986D0 (no) | Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter. | |
| NO167807C (no) | Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater. | |
| NO903347D0 (no) | Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener. | |
| NO862390D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. | |
| NO891574D0 (no) | Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser. | |
| NO894516D0 (no) | Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter. | |
| NO882028L (no) | Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner. | |
| NO880409D0 (no) | Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler. | |
| NO871484L (no) | Fremgangsmaate for fremstilling av n-(sulfonylmetyl) formamider. | |
| NO883987D0 (no) | Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter. | |
| NO901892L (no) | Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter. | |
| NO891987D0 (no) | Fremgangsmaate for fremstilling av n-substituerte fenyltioaniliner, fenylsulfinylaniliner og fenylsulfonylaniliner. | |
| NO913388L (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater. | |
| NO883525L (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater. | |
| NO883526L (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater. |